Related Experiment Video
Updated: Nov 23, 2025
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.6K
Should We Target Global Risk or Risk Factors?
Lale Tokgozoglu1, Duygu Kocyigit2
1Department of Cardiology, Hacettepe University Faculty of Medicine, 06100, Ankara, Turkey. lalet@hacettepe.edu.tr.
Current Atherosclerosis Reports
|January 4, 2021
Summary
New guidelines for dyslipidemia management emphasize accurate cardiovascular risk estimation and lowering low-density lipoprotein cholesterol (LDL-C). Focusing on LDL-C as the primary target helps prevent cardiovascular events, especially in high-risk individuals.
Area of Science:
- Cardiology
- Lipidology
- Preventive Medicine
Background:
- Dyslipidemia management is evolving with new evidence.
- Accurate cardiovascular risk stratification is crucial for guiding treatment intensity.
Purpose of the Study:
- To review current guidelines for dyslipidemia management.
- To highlight the importance of risk estimation and subclinical disease detection.
- To discuss contemporary approaches to lipid-lowering therapy.
Main Methods:
- Review of recent scientific evidence and clinical guidelines.
- Analysis of risk prediction models and their limitations.
- Discussion of therapeutic targets and strategies for dyslipidemia.
Main Results:
- Low-density lipoprotein cholesterol (LDL-C) is the primary therapeutic target.
- High-intensity lipid-lowering strategies are beneficial, particularly for very high-risk patients.
- Incorporating genetic scores, biomarkers, and imaging may improve risk prediction.
Conclusions:
- Global risk assessment is essential for cardiovascular disease prevention.
- Targeting modifiable risk factors like LDL-C is paramount.
- Lowering LDL-C goals can reduce future cardiovascular events in high-risk populations.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
269
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
269
01:12Relative Risk
1.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.2K
01:25Strategies for Assessing and Addressing Confounding
227
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
227
01:12Hazard Ratio
383
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
383
01:29Bias in Epidemiological Studies
990
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
990
01:20Comparing the Survival Analysis of Two or More Groups
408
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
408